Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
0.840
+0.009 (1.11%)
At close: Nov 22, 2024, 4:00 PM
0.805
-0.035 (-4.17%)
After-hours: Nov 22, 2024, 7:56 PM EST
Hoth Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 4.69 | 4.21 | 6.13 | 6.57 | 4.41 | 5.06 | |
Research & Development | 2.84 | 3.48 | 4.93 | 7.53 | 2.89 | 2.12 | |
Other Operating Expenses | - | - | - | - | - | 0.54 | |
Operating Expenses | 7.53 | 7.69 | 11.07 | 14.1 | 7.3 | 7.71 | |
Operating Income | -7.53 | -7.69 | -11.07 | -14.1 | -7.3 | -7.71 | |
Interest & Investment Income | 0.04 | 0.05 | 0.07 | - | 0.03 | 0.01 | |
Currency Exchange Gain (Loss) | - | - | - | - | - | -0 | |
Other Non Operating Income (Expenses) | -0 | - | 0.45 | -0.06 | 0.02 | - | |
EBT Excluding Unusual Items | -7.49 | -7.64 | -10.55 | -14.16 | -7.25 | -7.71 | |
Gain (Loss) on Sale of Investments | -0.02 | -0.2 | -0.82 | -0.15 | 0.05 | 0 | |
Pretax Income | -7.51 | -7.85 | -11.37 | -14.31 | -7.2 | -7.7 | |
Net Income | -7.51 | -7.85 | -11.37 | -14.31 | -7.2 | -7.7 | |
Preferred Dividends & Other Adjustments | - | - | -0 | - | - | - | |
Net Income to Common | -7.51 | -7.85 | -11.37 | -14.31 | -7.2 | -7.7 | |
Shares Outstanding (Basic) | 6 | 3 | 1 | 1 | 0 | 0 | |
Shares Outstanding (Diluted) | 6 | 3 | 1 | 1 | 0 | 0 | |
Shares Change (YoY) | 113.34% | 184.69% | 34.07% | 80.63% | 34.90% | 82.16% | |
EPS (Basic) | -1.33 | -2.30 | -9.50 | -16.02 | -14.56 | -21.02 | |
EPS (Diluted) | -1.33 | -2.30 | -9.50 | -16.02 | -14.56 | -21.02 | |
Free Cash Flow | -8.02 | -8.45 | -9.3 | -12.09 | -6.13 | -4.95 | |
Free Cash Flow Per Share | -1.42 | -2.48 | -7.76 | -13.54 | -12.40 | -13.50 | |
EBITDA | - | - | - | -14.1 | -7.3 | -7.71 | |
D&A For EBITDA | - | - | - | 0 | 0 | 0 | |
EBIT | -7.53 | -7.69 | -11.07 | -14.1 | -7.3 | -7.71 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.